126 related articles for article (PubMed ID: 15301685)
1. Hepatitis C virus infection in intravenous drug users.
Harder J; Walter E; Riecken B; Ihling C; Bauer TM
Clin Microbiol Infect; 2004 Aug; 10(8):768-70. PubMed ID: 15301685
[TBL] [Abstract][Full Text] [Related]
2. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
Matheï C; Buntinx F; Van Damme P
J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
[No Abstract] [Full Text] [Related]
3. Hepatitis C virus serology in parenteral drug users with chronic liver disease.
Novick DM; Reagan KJ; Croxson TS; Gelb AM; Stenger RJ; Kreek MJ
Addiction; 1997 Feb; 92(2):167-71. PubMed ID: 9158228
[TBL] [Abstract][Full Text] [Related]
4. Clearance of hepatitis C virus after newly acquired infection in injection drug users.
Jauncey M; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson W; Kaldor JM; van Beek I; Dore GJ
J Infect Dis; 2004 Oct; 190(7):1270-4. PubMed ID: 15346337
[TBL] [Abstract][Full Text] [Related]
5. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
[TBL] [Abstract][Full Text] [Related]
8. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis.
McMahon JM; Pouget ER; Tortu S
J Infect Dis; 2007 Jun; 195(11):1572-81. PubMed ID: 17471426
[TBL] [Abstract][Full Text] [Related]
9. Analysis of causes for liver function deterioration in patients with HIV/HCV co-infection.
Zhang YH; Chen XY; Jiang Y; Xiao Y; Liu Z; Long XS; Wu H
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):538-42. PubMed ID: 15567741
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in Egyptian children: single centre experience.
El-Raziky MS; El-Hawary M; El-Koofy N; Okasha S; Kotb M; Salama K; Esmat G; El-Raziky M; Abouzied AM; El-Karaksy H
J Viral Hepat; 2004 Sep; 11(5):471-6. PubMed ID: 15357655
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
12. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
15. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
16. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
17. Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.
van de Laar TJ; Langendam MW; Bruisten SM; Welp EA; Verhaest I; van Ameijden EJ; Coutinho RA; Prins M
J Med Virol; 2005 Dec; 77(4):509-18. PubMed ID: 16254983
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil.
Mussi AD; Pereira RA; Corrêa e Silva Vde A; Martins RM; Souto FJ
Acta Trop; 2007; 104(2-3):116-21. PubMed ID: 17888391
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
